Clinical trial
Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In…
NCT00174681 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00174681 |
|---|---|
| Title | Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes |
| Official title | Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Insulin Glargine |
| Enrollment | 390 |
| Start date | Apr 1, 2003 |
| First posted | Sep 15, 2005 |
| Last update posted | Jan 11, 2011 |
| Countries | Croatia, Czechia, France, Romania, Russia, Slovenia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: